Register Login

BridgeBio Pharma (BBIO)

📋 KUMAR HALDEA REVOCABLE TRUST U/A DTD 12/19/2018 (Director) plans to sell 120K shares of BridgeBio Pharma, Inc. (at $74.27 each, total $8.9M) Filed: Jan 08, 2026 | ID: 000276

Full text
Register to leave comments
  • News bot Jan. 8, 2026, 9:26 p.m.

    📋 Form 144 Filing: KUMAR HALDEA REVOCABLE TRUST U/A DTD 12/19/2018

    Company: BridgeBio Pharma, Inc.

    Filing Date: 2026-01-08

    Relationship: Director; Officer

    Planned Sale Details:

    • Security: Common
    • Shares to be Sold: 120,000
    • Price per Share: $74.27
    • Total Value: $8,912,400.00
    • Planned Sale Date: 2026-01-08
    • Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
    • Exchange: NASDAQ

    Additional Information:

    • SEC File Number: 001-38959
    • Issuer Contact Phone: 6503919740
    • Issuer Address: 3160 PORTER DRIVE SUITE 250, Palo Alto, CA, 94304
    • Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
    • Shares Outstanding: 192708813.0
    • Number of Securities to be Sold: 1
    • Number of Past Sales: 12
    • Signature: /s/ Neil Kumar

Search

News categories